increase in pfs for platinum-resistant advanced oc
Published 5 years ago • 59 plays • Length 3:21Download video MP4
Download video MP3
Similar videos
-
6:57
case 4: i-o therapy for platinum-resistant recurrent disease
-
5:40
diagnosis of metastatic platinum-resistant ovarian cancer
-
1:47
mirvetuximab soravtansine remains well tolerated in platinum-resistant ovarian cancer
-
9:05
case 4: recurrent ovarian cancer, platinum-resistant, brca wt
-
14:46
managing platinum-resistant ovarian cancer
-
6:02
pfs increase but no os increase for niraparib in advanced ovarian cancer
-
42:00
prospects for targeted therapy in ovarian cancer - by michael birrer, md, phd
-
4:07
approaching platinum-refractory recurrent ovarian cancer
-
1:09
dr. arend on unmet needs in platinum-resistant ovarian cancer
-
28:44
updates on promising progress in platinum resistant ovarian cancer
-
1:19
relacorilant nab-paclitaxel in recurrent, platinum-resistant ovarian cancer
-
27:14
maintenance therapy in platinum resistant and platinum sensitive ovarian cancer
-
1:41
unmet clinical needs for platinum-resistant ovarian cancer patients
-
4:23
safety and tolerability of avb500 in platinum-resistant recurrent ovarian cancer
-
4:40
asco 2023 highlights on the mirasol trial in pt-resistant adv. high-grade epithelial ovarian cancer
-
24:53
parp inhibitors in platinum sensitive & platinum resistant ovarian cancers
-
42:00
prospects for targeted therapy in ovarian cancer
-
2:25
results of niraparib/bevacizumab combo in platinum-sensitive recurrent ovarian cancer
-
2:20
dr. matulonis discusses niraparib/pembrolizumab combo in platinum-resistant ovarian cancer